“Body Contouring Devices and Procedures Market Report is set to have rapid growth due to the factors, such as quick adoption of technologically advanced products, high domestic income, and rise in demand for noninvasive procedures at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Body Contouring Devices and Procedures Market Forecast 2019-2029: By Device Type, By Procedure Type (Cellulite Treatment, Liposuction), By End Use, And Segment Forecasts
One of the major reason for increasing demand for body contouring devices and procedures is rising cases of obesity across the globe due to unhealthy lifestyle. The increased life expectancy resulting from the improved safety and efficacy of body contouring devices, besides their ease of use, cost-effective, and less painful has also resulted in the growth of the market. Moreover, initiatives, such as M&A and partnerships, undertaken by major companies for product research and distribution are also fuelling the market growth. The technological development in this segment will fuel its growth.
The market is divided into segments of non-invasive and minimally invasive which holds the major share of the market. This segment also witness massive R&D by the key players which has enhanced safety, short downtimes, and cost-effectiveness of these devices and the procedures.
The clinics and spa centres are the major players in this segment owing to technologically advanced devices and reduced risks of hospital-acquired infections.
Leading companies featured in the report include: Cynosure, Inc., Alma Lasers, Alleragan, Syneron Medical Ltd., Bausch Health Companies, Inc., Lumenis, Merz Pharma, Meridian, InMode Aesthetic Solutions, El.En. S.p.A. (Asclepion Laser Technologies GmbH).
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Gene Amplification Technologies market was valued at US$4,587 million in 2022 and is projected to grow at a CAGR of 9.8% during the forecast period 2023-2033.
05 December 2022
The global stem cell technologies and applications market was valued at US$9,247 million in 2021 and is projected to grow at a CAGR of 8.9% during the forecast period 2022-2032.
01 December 2022
The biosimilars and follow-on biologics market is valued at US$19,668.3 million in 2022 and is projected to grow at a CAGR of 31.14% during the forecast period 2023-2033.
01 December 2022
The Medical Imaging market was valued at US$38.6 billion in 2021 and is projected to grow at a CAGR of 5.46% during the forecast period 2022-2032.